Consistent with the expectation from previous results, there was a significantly increased fraction of central memory cells in CLL-CAR-T cells 15 days after PF-06465469 treatment (Figure 7, K and L), suggesting that ITK inhibition could also promote T cell memory in CD19-CAR-T cells generated from CLL patients. Here, CD19 is linked to B-cell chronic lymphocytic leukemia.